Intertek and DFE Pharma invite you to join our webinar on developing biologics for respiratory delivery and how current strategies for dry powder inhaler (DPI) formulation can provide effective solutions
WEBINAR
The Challenges of Developing Biologics for Respiratory Delivery & How Current Strategies for Dry Powder Formulation Can Provide Effective and Novel Solutions
Developing biologics for respiratory delivery presents a range of new challenges and numerous factors need to combine to deliver a safe and efficacious drug product. The device, formulation, active substance, excipients and manufacturing processes all influence the performance, usability and functionality of the product and need careful consideration during development. During this webinar, DFE Pharma and Intertek will review key concepts and techniques in the formulation, design, and performance testing of the formulation of biologics for Dry Powder Inhalation. Topics will include stabilization of biologics and carrier-free particle engineering, as well as analytical approaches to characterise these products. Original broadcast date: April 2023.
Supercharge your DPI development for biologics, sign up for our webinar now.
Select a session to meet your schedule:
Meet our Experts:
Mark Parry has worked with Intertek Melbourn for over 20 years after graduating from Cambridge University and currently works as the Technical Director supporting the wide range of analytical, formulation and product development activities across the company. Mark has worked in a range of pharmaceutical analysis and formulation development areas with a particular focus on inhaled and nasal drug products. Mostly working in the pre-approval stages, Mark’s background includes extensive experience with product and formulation development, as well as method development and validation, stability studies, and pharmaceutical development activities for a wide range of clients across the pharmaceutical industry. Learn more about Intertek's Inhalation Drug Development Expertise
Ross Blezard is a Product and Application Specialist Biopharma at DFE Pharma. A physicist by education, Ross began his career in inhalation and transdermal delivery. After leaving his position as head of formulation development at a UK based CDMO, Ross spent 6 years working as a senior scientist in material sciences. In 2019 Ross joined DFE Pharma where he has supported inhalation and biopharmaceutical customers with their technical challenges. Learn more about DFE Pharma | DFE Pharma Privacy Policy
